Ophthalmic Drug Delivery for out-licensing
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT05992922
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 17, 2023
Completion: Dec 19, 2023
Loading map...